Robert Lugo
Family Medicine · Buffalo, NYNPI 1700179827
Payments from drug & device makers
Across 51 payments — averaging $49.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$623
- Abbott$483
- Saluda Medical Americas, Inc.$290
- MML US, Inc.$245
- Exact Sciences$150
- Insulet Corporation$145
- plus $607 from 18 others
What the payments were for
- Travel & lodging$47619%
- Food & beverage$2,06681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 2 | $623 |
| Abbott | 12 | $483 |
| Saluda Medical Americas, Inc. | 8 | $290 |
| MML US, Inc. | 1 | $245 |
| Exact Sciences | 2 | $150 |
| Insulet Corporation | 2 | $145 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Merck | 3 | $51 |
| Nevro Corp. | 2 | $49 |
| Novo Nordisk | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 1 | $29 |
| AstraZeneca | 1 | $26 |
| Boston Scientific | 1 | $25 |
| Pfizer | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| GSK | 1 | $20 |
| AbbVie | 1 | $19 |
| GRT US Holding, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$623
- PROCLAIM$290
- ReActiv8$245
- The Cologuard Plus Collection Kit$125
- Omnipod$125
- COBENFY$125
How this compares
$2,542 in reported general payments places this provider in the 80th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 34 | $39,284 |
| EliquisApixaban | 37 | $32,255 |
| OzempicSemaglutide | 23 | $22,880 |
| JardianceEmpagliflozin | 25 | $21,048 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $4,270 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,456 |
| Ramelteon | 22 | $2,295 |
| Clonidine | 13 | $2,179 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,969 |
| Rosuvastatin Calcium | 27 | $1,244 |
| Atorvastatin Calcium | 100 | $984 |
| Amlodipine Besylate | 141 | $881 |
| Diltiazem 24hr ErDiltiazem Hcl | 22 | $718 |
| Chlorthalidone | 29 | $664 |
| Lisinopril | 58 | $636 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $21 | $39,28434 claims |
| PfizerEliquis | $22 | $32,25537 claims |
| Novo NordiskOzempic | $42 | $22,88023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,321 family medicine providers in New York.
Other family medicine in Buffalo
- Martin MahoneyBuffalo$640K
- Ryan BoweBuffalo$200K
- Chester FoxBuffalo$42K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.